MWA Combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma

International Journal of Hyperthermia

Volumn 27, Issue 7, 2011, Pages 654-662

  Liu, Cun ^a,b   Liang, Ping ^a   Liu, Fangyi ^a   Wang, Yang ^a   Li, Xin ^a   Han, Zhiyu ^a   Liu, Changchun ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma (HCC); Microwave ablation (MWA); Transcatheter arterial chemoembolization (TACE)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; STUDENT T TEST; THERAPY EFFECT; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; SURVIVAL RATE;

EID: 80054078479     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2011.605099     Document Type: Article

References (48)

1. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19(3):271-285, Review. (Pubitemid 29488770)
2. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, Cammà C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 2010;51(4):1274-1283.
3. Shimada M, Yamashita Y, Hamatsu T, Rikimaru T, Hasegawa H, Gion T, Shirabe K, Takenaka K, Sugimachi K. Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology. 2000 Jul-Aug;47 (34):1095-1099.
4. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996 Jan;131(1):71-76. (Pubitemid 26015411)
5. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005;9: 1207-1215, discussion 1215. (Pubitemid 41751112)
6. Benzoni E, Molaro R, Cedolini C, Favero A, Cojutti A, Lorenzin D, Intini S, Adani GL, Baccarani U, Bresadola F, et al. Liver resection for HCC: Analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology 2007;54: 186-189. (Pubitemid 46511672)
7. Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, Tsai CC, Chen IS, Yeh MH, Chen YC. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg. 2003 Nov;197(5):730-738.
8. Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB, 2005;7: 42-49. (Pubitemid 40425756)
9. Llovet JM, Fuster J, Bruix J. The Barcelona approach: Diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transplantation, 2004;10: S115-S120. (Pubitemid 38240111)
10. Beaugrand M, Seror O. Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: Present status and future developments. Curr Pharm Des. 2007;13(32):3274-3278. (Pubitemid 350201681)
11. Wang ZL, Liang P, Dong BW, Yu XL, Yu DJ. Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study. J Gastrointest Surg. 2008 Feb; 12(2):327-337.
12. Hinshaw JL, Lee Jr FT. Cryoablation for liver cancer. Tech Vasc Interv Radiol. 2007 Mar;10(1):47-57. (Pubitemid 350008080)
13. Marquet F, Pernot M, Aubry JF, Tanter M, Montaldo G, Fink M. In-vivo non-invasive motion tracking and correction in High Intensity Focused Ultrasound therapy. Conf Proc IEEE Eng Med Biol Soc. 2006;1:688-691. (Pubitemid 46519956)
14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323-331. (Pubitemid 30067129)
15. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000;217:633-646.
16. Farinati F, De Maria N, Marafin C, et al. Unresectable hepatocellular carcinoma in cirrhosis: Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 1996;41:2332-2339.
17. Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues. Hepatology 1998;27:1743-1744. (Pubitemid 28264704)
18. Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001;219:669-678. (Pubitemid 32476256)
19. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: Treatment with high-intensity focusedultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005 May;235(2):345-346.
20. Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, et al. Large-sized hepatocellular carcinoma (HCC): A neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. 2007 Feb;17(2):553-563. (Pubitemid 46140327)
21. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006 Mar;16(3):661-669. (Pubitemid 44149378)
22. Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):159-169.
23. Giuseppe Cabibbo, Antonio Craxì. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol. 2009 Oct 31;1(1):62-66.
24. Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: A meta-analysis. Liver Int. 2010;30(5):741-749.
25. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K. Percutaneous microwave coagulation therapy for patients with small hepatocellular carinoma: Comparison with percutaneous ethanol injection therapy. Cancer 1999;85: 1694-1702. (Pubitemid 29169669)
26. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223:331-337. (Pubitemid 34454307)
27. Ren H, Liang P, Yu X, Wang Y, Lu T, Li X. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethanol injection: A pilot study. Int J Hyperthermia.2011;27(3):249-254.
28. Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915MHz microwave ablation and 2450MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia.2010;26(5):448-455.
29. Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients. AJR 2003;180:1547-1555. (Pubitemid 36687082)
30. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235: 299-307. (Pubitemid 40432267)
31. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study. J Gastroenterol 2005;40: 1054-1060. (Pubitemid 43055290)
32. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, Ikeda K, Inoue K. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. 2000 Sep 15;89(6):1245-1251.
33. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989;19:98-129.
34. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag; 2003.
35. Tancredi T, McCuskey PA, Kan Z, Wallace S. Changes in rat liver microcirculation after experimental hepatic arterial embolization: Comparison of different embolic agents. Radiology. 1999 Apr;211(1):177-181. (Pubitemid 29161748)
36. Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol. 2002 Dec;13(12):1225-1232. (Pubitemid 35440314)
37. Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72(Suppl 1):124-131. (Pubitemid 350256676)
38. Iannitti DA, Martin RC, Simon CJ, Hope WW, Newcomb WL, McMasters KM, Dupuy D. Hepatic tumor ablation with clustered microwave antennae: The US Phase II Trial. HPB (Oxford)2007;9(2):120-124. (Pubitemid 46672385)
39. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: Challenges and opportunities, part I. J Vasc Interv Radiol 2001;12(9):1021-1032. (Pubitemid 32844849)
40. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006 Mar;16(3):661-669. (Pubitemid 44149378)
41. Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, et al. Large-sized hepatocellular carcinoma (HCC): A neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. 2007 Feb;17(2):553-563. (Pubitemid 46140327)
42. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005 May;235(2):659-667. (Pubitemid 40571111)
43. keda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991;68:2150-2154.
44. Bruix J, Castells A, Montanyà X, Calvet X, Brú C, Ayuso C, Jover L, García L, Vilana R, Boix L, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials. Hepatology 1994;20:643-650. (Pubitemid 24271273)
45. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359:1734-1739. (Pubitemid 34607087)
46. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164-1171. (Pubitemid 34454013)
47. Lim HS, Jeong YY, Kang HK, Kim JK, Park JG. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. AJR Am J Roentgenol. 2006 Oct;187(4):W341-349.
48. Junji Furuse. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Biologics. 2008 Dec;2(4):779-788.